000 01188 a2200361 4500
005 20250515103458.0
264 0 _c20080806
008 200808s 0 0 fre d
022 _a0369-8114
024 7 _a10.1016/j.patbio.2007.09.011
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGarcia Hejl, C
245 0 0 _a[Fondaparinux: the present and the future].
_h[electronic resource]
260 _bPathologie-biologie
_cMar 2008
300 _a97-103 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnticoagulants
_xpharmacology
650 0 4 _aBlood Coagulation
650 0 4 _aCysteine Endopeptidases
650 0 4 _aDrug Interactions
650 0 4 _aFondaparinux
650 0 4 _aHumans
650 0 4 _aNeoplasm Proteins
_xantagonists & inhibitors
650 0 4 _aPolysaccharides
_xpharmacology
650 0 4 _aThromboembolism
_xprevention & control
700 1 _aGarcia, C
700 1 _aThefenne-Astier, H
700 1 _aServonnet, A
700 1 _aSamson, T
700 1 _aFoissaud, V
773 0 _tPathologie-biologie
_gvol. 56
_gno. 2
_gp. 97-103
856 4 0 _uhttps://doi.org/10.1016/j.patbio.2007.09.011
_zAvailable from publisher's website
999 _c17688380
_d17688380